Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Abbott Laboratories property, Plant & Equipment — Gross Carrying Value ($M) ($M)
Form 10-K / 10-Q Supplemental Financial Information Footnote & Item 2 (Properties)
Latest, Q2 2026
26,469
Period ended Jun 30, 2026
Change on a year earlier
+8.2%
24,472 in Q2 2025
History
54 quarters
Since Q1 2013
Sources
42
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Property, Plant & Equipment — Gross Carrying Value ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 26,469 | +8.2% | SEC Filing (0001628280-26-050134) ↗ |
| Q1 2026 | Mar 31, 2026 | 25,737 | +9.9% | SEC Filing (0001628280-26-028357) ↗ |
| Q4 2025 | Dec 31, 2025 | 25,222 | +10.9% | SEC Filing (0001628280-26-050134) ↗ |
| Q3 2025 | Sep 30, 2025 | 24,816 | +8.6% | SEC Filing (0001628280-25-047131) ↗ |
| Q2 2025 | Jun 30, 2025 | 24,472 | +10.9% | SEC Filing (0001628280-25-036720) ↗ |
| Q1 2025 | Mar 31, 2025 | 23,418 | +6.2% | SEC Filing (0001628280-25-021090) ↗ |
| Q4 2024 | Dec 31, 2024 | 22,740 | +3.7% | SEC Filing (0001628280-26-010185) ↗ |
| Q3 2024 | Sep 30, 2024 | 22,857 | +8.3% | SEC Filing (0001628280-24-044602) ↗ |
| Q2 2024 | Jun 30, 2024 | 22,061 | +5.4% | SEC Filing (0001628280-24-033740) ↗ |
| Q1 2024 | Mar 31, 2024 | 22,055 | +7.0% | SEC Filing (0001628280-24-020011) ↗ |
| Q4 2023 | Dec 31, 2023 | 21,933 | +8.5% | SEC Filing (0001628280-25-007110) ↗ |
| Q3 2023 | Sep 30, 2023 | 21,111 | +9.3% | SEC Filing (0001628280-23-035957) ↗ |
| Q2 2023 | Jun 30, 2023 | 20,926 | +7.5% | SEC Filing (0001628280-23-027203) ↗ |
| Q1 2023 | Mar 31, 2023 | 20,605 | +5.6% | SEC Filing (0001628280-23-015699) ↗ |
| Q4 2022 | Dec 31, 2022 | 20,212 | +4.4% | SEC Filing (0001628280-24-005348) ↗ |
| Q3 2022 | Sep 30, 2022 | 19,306 | +0.6% | SEC Filing (0001628280-22-027550) ↗ |
| Q2 2022 | Jun 30, 2022 | 19,458 | +2.0% | SEC Filing (0001628280-22-020209) ↗ |
| Q1 2022 | Mar 31, 2022 | 19,521 | +4.4% | SEC Filing (0001104659-22-055285) ↗ |
| Q4 2021 | Dec 31, 2021 | 19,364 | +3.0% | SEC Filing (0001628280-23-004026) ↗ |
| Q3 2021 | Sep 30, 2021 | 19,182 | +6.7% | SEC Filing (0001104659-21-133629) ↗ |
| Q2 2021 | Jun 30, 2021 | 19,074 | +9.8% | SEC Filing (0001104659-21-100055) ↗ |
| Q1 2021 | Mar 31, 2021 | 18,697 | +11.9% | SEC Filing (0001104659-21-061693) ↗ |
| Q4 2020 | Dec 31, 2020 | 18,793 | +11.9% | SEC Filing (0001104659-22-025141) ↗ |
| Q3 2020 | Sep 30, 2020 | 17,972 | +10.0% | SEC Filing (0001104659-20-121336) ↗ |
| Q2 2020 | Jun 30, 2020 | 17,374 | +6.4% | SEC Filing (0001104659-20-087850) ↗ |
| Q1 2020 | Mar 31, 2020 | 16,707 | +5.0% | SEC Filing (0001104659-20-053384) ↗ |
| Q4 2019 | Dec 31, 2019 | 16,799 | +7.0% | SEC Filing (0001104659-21-025751) ↗ |
| Q3 2019 | Sep 30, 2019 | 16,343 | +5.3% | SEC Filing (0001104659-19-058323) ↗ |
| Q2 2019 | Jun 30, 2019 | 16,331 | +6.7% | SEC Filing (0001410578-19-000606) ↗ |
| Q1 2019 | Mar 31, 2019 | 15,905 | +2.2% | SEC Filing (0001104659-19-026018) ↗ |
| Q4 2018 | Dec 31, 2018 | 15,706 | +2.9% | SEC Filing (0001104659-20-023904) ↗ |
| Q3 2018 | Sep 30, 2018 | 15,520 | +5.6% | SEC Filing (0001104659-18-065076) ↗ |
| Q2 2018 | Jun 30, 2018 | 15,309 | +5.8% | SEC Filing (0001104659-18-048736) ↗ |
| Q1 2018 | Mar 31, 2018 | 15,556 | +9.8% | SEC Filing (0001104659-18-029831) ↗ |
| Q4 2017 | Dec 31, 2017 | 15,265 | +23.4% | SEC Filing (0001047469-19-000624) ↗ |
| Q3 2017 | Sep 30, 2017 | 14,698 | +18.0% | SEC Filing (0001104659-17-065654) ↗ |
| Q2 2017 | Jun 30, 2017 | 14,476 | +13.9% | SEC Filing (0001104659-17-048855) ↗ |
| Q1 2017 | Mar 31, 2017 | 14,172 | +11.5% | SEC Filing (0001104659-17-029430) ↗ |
| Q4 2016 | Dec 31, 2016 | 12,366 | -0.1% | SEC Filing (0001047469-18-000856) ↗ |
| Q3 2016 | Sep 30, 2016 | 12,452 | -0.6% | sec_companyfacts ↗ |
| Q2 2016 | Jun 30, 2016 | 12,712 | +2.2% | sec_companyfacts ↗ |
| Q1 2016 | Mar 31, 2016 | 12,709 | +3.7% | sec_companyfacts ↗ |
| Q4 2015 | Dec 31, 2015 | 12,383 | -2.0% | SEC Filing (0001047469-17-000744) ↗ |
| Q3 2015 | Sep 30, 2015 | 12,528 | -1.3% | sec_companyfacts ↗ |
| Q2 2015 | Jun 30, 2015 | 12,433 | -5.1% | sec_companyfacts ↗ |
| Q1 2015 | Mar 31, 2015 | 12,251 | -5.8% | sec_companyfacts ↗ |
| Q4 2014 | Dec 31, 2014 | 12,632 | -1.8% | SEC Filing (0001047469-16-010246) ↗ |
| Q3 2014 | Sep 30, 2014 | 12,694 | -0.2% | sec_companyfacts ↗ |
| Q2 2014 | Jun 30, 2014 | 13,096 | +4.6% | sec_companyfacts ↗ |
| Q1 2014 | Mar 31, 2014 | 13,005 | +4.7% | sec_companyfacts ↗ |
| Q4 2013 | Dec 31, 2013 | 12,870 | – | SEC Filing (0001047469-15-001377) ↗ |
| Q3 2013 | Sep 30, 2013 | 12,714 | – | sec_companyfacts ↗ |
| Q2 2013 | Jun 30, 2013 | 12,520 | – | sec_companyfacts ↗ |
| Q1 2013 | Mar 31, 2013 | 12,417 | – | sec_companyfacts ↗ |
Breakdown
What makes up property, plant & equipment — gross carrying value ($m)
- Machinery & Equipment — Gross ($M)17,571 · Q4 2025
- Buildings — Gross ($M)4,543 · Q4 2025
- Construction in Progress ($M)2,567 · Q4 2025
- Land ($M)541 · Q4 2025
- Accumulated Depreciation ($M)13,657 · Q2 2026
- Global Manufacturing Facilities — Worldwide Total (Sites)–
- Owned & Leased Facilities Total Floor Area (Million Sq. Ft.)–
- Share of Total Facilities Floor Area Owned by Abbott (%)–
Cite this data
StockData. (2026). Abbott Laboratories Property, Plant & Equipment — Gross Carrying Value ($M) ($M), quarterly Q1 2013–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/xbrl-ppe-gross
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.